Substrate reduction therapy is a therapeutic strategy within biochemistry and medical research focused on mitigating the effects of metabolic disorders, particularly lysosomal storage diseases. This academic concept investigates methods to reduce the cellular accumulation of problematic substrates by inhibiting the synthesis of the substrate itself or its precursors, thereby aiming to restore cellular function and alleviate pathological symptoms. Its significance lies in providing a targeted approach for conditions where deficient enzyme activity leads to toxic substrate buildup, offering a potential means to slow disease progression and improve patient outcomes.